Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCadrenal Therapeutics, Inc. Common Stock Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$2.15 | -$2.15 | -$2.15 |
| Q2 2025 | 1 | -$1.26 | -$1.26 | -$1.26 |
| Q3 2025 | 1 | -$1.39 | -$1.39 | -$1.39 |
| Q4 2025 | 1 | -$1.42 | -$1.42 | -$1.42 |
Cadrenal Therapeutics, Inc. Common Stock Earnings Date And Information
Cadrenal Therapeutics, Inc. Common Stock last posted its earnings results on Thursday, November 7th, 2024. The company reported $-2.18 earnings per share for the quarter, missing analysts' consensus estimates of $-1.83 by $0.35. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Cadrenal Therapeutics, Inc. Common Stock has generated $-10 earnings per share over the last year ($-9.63 diluted earnings per share) and currently has a price-to-earnings ratio of -2.56. Cadrenal Therapeutics, Inc. Common Stock has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
Cadrenal Therapeutics, Inc. Common Stock Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$1.83 | -$2.18 | -0.35 | $0 | $0 |
| 08/07/2024 | Q2 2024 | -$19.04 | -$2.24 | 16.8 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$1.05 | -$1.55 | -0.5 | N/A | $0 |
| 03/08/2024 | Q4 2023 | -$1.35 | -$1.32 | 0.03 | N/A | $2,768 |
| 11/09/2023 | Q3 2023 | -$1.05 | -$1.19 | -0.14 | N/A | $0 |
| 08/10/2023 | Q2 2023 | N/A | -$1.28 | N/A | N/A | $0 |
| 05/10/2023 | Q1 2023 | N/A | -$6.62 | N/A | N/A | $0 |
| 03/29/2023 | Q4 2022 | N/A | -$6.46 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.09 | N/A | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$0.04 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$0.02 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cadrenal Therapeutics, Inc. Common Stock Earnings: FAQ's
Cadrenal Therapeutics, Inc. Common Stock has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based offlast year's report dates.
The conference call for Cadrenal Therapeutics, Inc. Common Stock's latest earnings report can be listened to online.
The conference call transcript for Cadrenal Therapeutics, Inc. Common Stock's latest earnings report can be read online.
Cadrenal Therapeutics, Inc. Common Stock (:CVKD) has a recorded net income of $-8,357,086.Cadrenal Therapeutics, Inc. Common Stock has generated $-9.63 earnings per share over the last four quarters.
Cadrenal Therapeutics, Inc. Common Stock (:CVKD) has a price-to-earnings ratio of -2.56 and price/earnings-to-growth ratio is 0.16.